Among six SFs, the level of SF3B4 in ACC cases with the tumor stage III and the level of PRCC and SF3B4 in ACC cases with stage IV were statistically different from those in stage I (Figure 9), which is consistent with the results from the GEPIA database (Supplementary Figure 3). This evidence concerns the gene PRCC and neoplasm.